SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 237 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $321,000 | +9.6% | 11,000 | 0.0% | 0.05% | +9.5% |
| Q3 2021 | $293,000 | -13.6% | 11,000 | 0.0% | 0.04% | -6.7% |
| Q2 2021 | $339,000 | +17.7% | 11,000 | 0.0% | 0.04% | +9.8% |
| Q1 2021 | $288,000 | -37.4% | 11,000 | -39.9% | 0.04% | -36.9% |
| Q4 2020 | $460,000 | +20.7% | 18,300 | 0.0% | 0.06% | 0.0% |
| Q3 2020 | $381,000 | -12.4% | 18,300 | 0.0% | 0.06% | -7.1% |
| Q2 2020 | $435,000 | +15.1% | 18,300 | -12.9% | 0.07% | +14.8% |
| Q1 2020 | $378,000 | -24.1% | 21,000 | 0.0% | 0.06% | +22.0% |
| Q4 2019 | $498,000 | +105.8% | 21,000 | +138.6% | 0.05% | +100.0% |
| Q3 2019 | $242,000 | – | 8,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |